IL163859A0 - Multiple and multivalent dna vaccines in ovo - Google Patents

Multiple and multivalent dna vaccines in ovo

Info

Publication number
IL163859A0
IL163859A0 IL16385903A IL16385903A IL163859A0 IL 163859 A0 IL163859 A0 IL 163859A0 IL 16385903 A IL16385903 A IL 16385903A IL 16385903 A IL16385903 A IL 16385903A IL 163859 A0 IL163859 A0 IL 163859A0
Authority
IL
Israel
Prior art keywords
ovo
dna vaccines
multivalent dna
multivalent
vaccines
Prior art date
Application number
IL16385903A
Other languages
English (en)
Original Assignee
Schweitzer Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schweitzer Chemical Corp filed Critical Schweitzer Chemical Corp
Publication of IL163859A0 publication Critical patent/IL163859A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL16385903A 2002-03-08 2003-03-06 Multiple and multivalent dna vaccines in ovo IL163859A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36254702P 2002-03-08 2002-03-08
US10/377,718 US7029681B2 (en) 2002-03-08 2003-03-04 Multiple and multivalent DNA vaccines in ovo
US0375843 2003-03-06

Publications (1)

Publication Number Publication Date
IL163859A0 true IL163859A0 (en) 2005-12-18

Family

ID=27807969

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16385903A IL163859A0 (en) 2002-03-08 2003-03-06 Multiple and multivalent dna vaccines in ovo
IL163859A IL163859A (en) 2002-03-08 2004-09-01 Multiple and multivalent dna vaccines in ovo

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL163859A IL163859A (en) 2002-03-08 2004-09-01 Multiple and multivalent dna vaccines in ovo

Country Status (10)

Country Link
US (1) US7029681B2 (xx)
EP (1) EP1490105B1 (xx)
JP (2) JP4999258B2 (xx)
CN (2) CN1646157B (xx)
AU (1) AU2003216531B2 (xx)
BR (1) BRPI0308365B1 (xx)
CA (1) CA2478081C (xx)
IL (2) IL163859A0 (xx)
MX (1) MXPA04008692A (xx)
WO (1) WO2003075843A2 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037506B2 (en) * 2002-03-08 2006-05-02 Schweltzer Chemical Corporation Ltd. Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry
US8956628B2 (en) * 2007-12-13 2015-02-17 Zoetis Products Llc Bacteriophage preparations and method of use thereof
CA2851658C (en) 2011-10-21 2022-03-15 Intervet International B.V. Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
BR112014008161A2 (pt) * 2011-10-21 2017-04-11 Intervet Int Bv vírus da doença de marek não patogênico recombinante, método para a preparação do mesmo, molécula do ácido nucleico, célula hospedeira, vacina para aves domésticas, método para a preparação de uma vacina, uso de um vírus da doença de marek não patogênico recombinante, e, método de vacinação de aves domésticas
EP2644702A1 (en) * 2012-03-30 2013-10-02 Ceva Sante Animale Multivalent recombinant avian herpes virus and vaccine for immunizing avian species
CN102895660B (zh) * 2012-10-25 2014-04-23 中国兽医药品监察所 一种鸭病毒性肝炎二价灭活疫苗
US9950059B2 (en) 2014-02-25 2018-04-24 The United States Of America, As Represented By The Secretary Of Agriculture. Immunogenic composition
CN110295149B (zh) * 2019-06-24 2022-06-24 四川农业大学 一种突变株3型鸭甲肝病毒ch-p60-117c株及构建方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3575A (en) * 1844-05-06 Improvement
US182241A (en) * 1876-09-12 Improvement in animal-traps
US4458630A (en) 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
IL91627A (en) * 1988-09-13 1995-08-31 Rhone Merieux Viral nucleotide segments
BR9007702A (pt) 1989-10-02 1992-08-18 Embrex Inc Metodo de tratamento
US5397568A (en) 1989-10-02 1995-03-14 Whitfill; Craig E. Method of treating infectious bursal disease virus infections
US5056464A (en) 1990-01-18 1991-10-15 Embrex, Inc. Automated injection system for avian embryos with advanced fluid delivery system
US5595912A (en) 1990-05-04 1997-01-21 University Of Maryland College Park Specific DNA and RNA sequences associated with US IBDV variants, vector carrying DNA sequences, host carrying cloned vector, deduced amino acid sequences, vaccine and method of vaccination
ZA924203B (en) 1991-06-18 1993-03-31 Akzo Nv Coccidiosis poultry vaccine
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
JPH06141853A (ja) * 1992-10-30 1994-05-24 Chemo Sero Therapeut Res Inst 組換え鶏伝染性喉頭気管炎ウイルス及びその製法
AU6299594A (en) * 1993-02-26 1994-09-14 Nippon Zeon Co., Ltd. Recombinant fowlpox virus s-fpv-043 and uses thereof
EP0745127A4 (en) 1994-01-11 1999-10-20 Cornell Res Foundation Inc CONTROLLING MARE'S DISEASE BY PREVENTING LATENCY AND DEVELOPING TUMOR CELLS
CA2192994A1 (en) 1994-06-20 1995-12-28 Henry D. Stone In ovo immunization of avian embryos with oil-emulsion vaccines
US5817320A (en) 1994-06-20 1998-10-06 The United States Of America As Represented By The Secretary Of The Agriculture In ovo immunization of avian embryos with oil-emulsion vaccines
JPH08116976A (ja) * 1994-10-20 1996-05-14 Chemo Sero Therapeut Res Inst 免疫用核酸調製物およびこれを用いた免疫方法
KR19990028766A (ko) 1995-07-07 1999-04-15 나카노 가쓰히꼬 마렉 질환 바이러스 유전자 및 마렉 질환 예방용 백신에서그의 용도
FR2751225B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
US5699751A (en) 1996-10-02 1997-12-23 Embrex, Inc. Method and apparatus for in ovo injection
US6048535A (en) 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
JP4091152B2 (ja) * 1997-09-19 2008-05-28 財団法人化学及血清療法研究所 金コロイドを含む核酸調製物
UY25347A1 (es) 1998-01-12 1999-05-14 Embrex Inc Procedimiento de inyeccion multiple para el tratamiento de embriones aviarios in ovo, y aparato automatizado para la inyeccion in ovo.
US6286455B1 (en) 1998-01-12 2001-09-11 Embrex, Inc. Automated in ovo injection apparatus

Also Published As

Publication number Publication date
BRPI0308365B1 (pt) 2016-12-27
MXPA04008692A (es) 2005-02-24
EP1490105B1 (en) 2013-10-02
EP1490105A4 (en) 2006-04-19
EP1490105A2 (en) 2004-12-29
CA2478081A1 (en) 2003-09-18
US7029681B2 (en) 2006-04-18
CA2478081C (en) 2011-04-19
JP2009203242A (ja) 2009-09-10
US20030175291A1 (en) 2003-09-18
IL163859A (en) 2010-05-17
JP4999258B2 (ja) 2012-08-15
CN1646157A (zh) 2005-07-27
CN101703770A (zh) 2010-05-12
AU2003216531A1 (en) 2003-09-22
CN1646157B (zh) 2011-03-02
WO2003075843A2 (en) 2003-09-18
BR0308365A (pt) 2005-09-06
WO2003075843A3 (en) 2004-07-22
AU2003216531B2 (en) 2006-11-30
JP2005519943A (ja) 2005-07-07

Similar Documents

Publication Publication Date Title
SI1673460T1 (sl) Rekombinantna cepiva in njihova uporaba
IL174131A0 (en) Improvements in vaccination
EP1804831A4 (en) VACCINES BASED ON LLO AND LISTERIA
EP1542717A4 (en) IMPROVEMENT RELATING TO VACCINES OR RELATED THERETO
GB0023008D0 (en) Improvements in vaccination
GB0206461D0 (en) Improvements in vaccination
EP1814393A4 (en) TOLEROGENIC VACCINE AND METHOD THEREOF
IL163859A0 (en) Multiple and multivalent dna vaccines in ovo
PL374569A1 (en) Vaccines
GB0423681D0 (en) Vaccine and nucleic acids
EP1660016A4 (en) NUCLEIC ACIDS, PROTEINS, SARS VACCINES AND USES THEREOF
AU2003243663A8 (en) Vaccines for suppressing ige-mediated allergic disease and methods for using the same
AU2003267361A8 (en) Orthopoxvirus antigens and use thereof
EP1583557A4 (en) VACCINE COMPOSITIONS AND METHODS
GB0127657D0 (en) Virulence genes and proteins and their use
GB0318546D0 (en) Quinoxalinones and their use
IL198505A0 (en) Multiple and multivalent dna vaccines in ovo
AU2003297833A8 (en) Canine rankl and methods for preparing and using the same
AU2003237701A8 (en) Vaccines
GB0214942D0 (en) Immunogenic proteins and DNA encoding these
GB0317376D0 (en) Immunogenic protein and uses thereof
GB2411357B (en) Vaccine for cold-water disease in fish
EP1617865A4 (en) IMPROVED HIV-1 VACCINES AND METHODS OF USE
GB2420345B (en) 3-alpha-glycosyl alpha, alpha-trehaloses their preparation and use
GB0226717D0 (en) DNA vaccination